Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-038556
Filing Date
2021-03-18
Accepted
2021-03-18 20:20:25
Documents
1
Period of Report
2020-07-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm217124-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm217124-8_4seq1.xml 4 3550
  Complete submission text file 0001104659-21-038556.txt   5244
Mailing Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437 203-643-8002
BioXcel LLC (Reporting) CIK: 0001651990 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 21756159
SIC: 7372 Services-Prepackaged Software

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations